Puma Biotechnology share price logo

Puma Biotechnology

NASDAQ: PBYI

Small Cap

$9.60

+0.08

(+0.84%)

as on

Puma Biotechnology Stock Performance

as on September 19, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $9.44
    $9.66
    downward going graph

    1.67%

    Downside

    0.63%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $4.37
    $9.74
    downward going graph

    54.48%

    Downside

    1.41%

    Upside

    downward going graph

Puma Biotechnology share price movements today

Previous Close
$9.52
Open
$9.54
Volume
311.1K
Market Cap
$491.4M
Day's Low - High
$9.44 - $9.66
52 Week Low - High
$4.37 - $9.74

Puma Biotechnology Historical Returns

1 Month Return
+ 0.32 %
3 Month Return
+ 25.93 %
1 Year Return
+ 115.38 %
3 Year Return
+ 219.46 %
5 Year Return
+ 37.97 %

Puma Biotechnology Stock Fundamentals & Key Indicators

Check Puma Biotechnology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$491.4M

EPS (TTM)

0.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

18.31

Industry PE ratio

-6.87

PEG Ratio

0.03

EBITDA

-

Revenue (TTM)

-

Profit Margin

11.55%

Return On Equity TTM

21.97%

Puma Biotechnology Stock Valuation

Track how Puma Biotechnology P/E has moved over time to understand its valuation trends.

Puma Biotechnology in the last 5 years

  • Overview

  • Trends

Lowest (-14.98x)

September 30, 2021

Industry (-6.87x)

September 19, 2026

Today (18.31x)

September 19, 2026

Highest (26.00x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: 18.31x

Puma Biotechnology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Puma Biotechnology with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$491.4M37.97%18.3111.55%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Puma Biotechnology Stock including INR - Dollar returns

The Puma Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Puma Biotechnology investment value today

Current value as on today

₹2,36,375

Returns

₹1,36,375

(+136.37%)

Returns from Puma Biotechnology Stock

₹1,17,195 (+117.19%)

Dollar Impact

₹19,180 (+19.18%)

Analyst Recommendation on Puma Biotechnology Stock

Based on 1 analysts

SELL

0.00%

Buy

100.00%

Hold

0.00%

Sell

Based on 1 analysts, 100% of analysts recommend a 'SELL' rating for Puma Biotechnology. Average target price of $6

Puma Biotechnology Share Price Target

Get share price movements and forecasts by analysts on Puma Biotechnology.

What analysts predicted

-60%DOWNSIDE

Target Price

$6

Current Price

$9.6

Analyzed by

1 Analysts

Target

$6.00

Puma Biotechnology target price $6, a slight downside of -60% compared to current price of $9.6. According to 1 analysts rating.

Indian Investors' Interest in Puma Biotechnology Stock

Search interest for Puma Biotechnology Stock has increased by 150% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:150% versus previous 30 day period

Puma Biotechnology Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
43
47
80
59
46
52
54
75
44
56
Gross Profit
33
36
51
45
35
40
42
52
34
44
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-4
-4
20
19
2
5
8
13
-3
8
Net Profit Margin
-11.00%
-9.62%
25.23%
32.68%
6.46%
11.17%
16.23%
17.81%
-8.37%
14.49%

Puma Biotechnology Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
27
251
272
225
253
228
235
230
228
Gross Profit
-1
22
216
235
185
189
172
172
166
170
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-276
-292
-113
-75
-59
-29
0
21
30
31
Net Profit Margin
0.00%
-1054.15%
-45.26%
-27.77%
-26.65%
-11.51%
0.00%
9.16%
13.14%
13.62%

Mutual Funds that own Puma Biotechnology Stock

Check out the Mutual Funds with significant holdings in Puma Biotechnology.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.423494%
1767210
VANGUARD EXPLORER FUND
1.505984%
777390
DFA INVESTMENT DIMENSIONS GROUP INC
1.455596%
751380
VANGUARD HORIZON FUNDS
1.177024%
607581
Bridgeway Funds, Inc.
1.091629%
563500

Global Institutional Holdings in Puma Biotechnology

Funds
Holdings
Avantis
4.9%
Vanguard
4.31%
iShares
3.65%
Dimensional
1.16%
Bridgeway
1.1%

Insights on Puma Biotechnology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, PBYI stock has moved up by 5.3%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.75M → 8.18M (in $), with an average increase of 145.8% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, PBYI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 44.81M → 56.50M (in $), with an average increase of 20.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 510.3% return, outperforming this stock by 393.1%

About Puma Biotechnology

Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care. Its lead drug candidate, orally administered neratinib (PB272), targets a range of indications. These include patients with early-stage HER2-overexpressed/amplified breast cancer, as well as adults suffering from advanced or metastatic HER2-positive breast cancer when used in combination with capecitabine. Furthermore, PB272 is being explored for solid tumors exhibiting HER2 mutations. The company holds a licensing agreement with Pfizer, Inc. for this drug and has established sub-licensing partnerships with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. Established in 2010, Puma Biotechnology maintains its headquarters in Los Angeles, California.
OrganisationPuma Biotechnology
Headquarters10880 Wilshire Boulevard, Los Angeles, CA, 90024, US
IndustryBiotechnology
CEOAlan H. Auerbach
E-voting on sharesClick here to vote

Key Management of Puma Biotechnology

Name

Title

Mr. Douglas Hunt B.Sc., FRAPS

Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer

Mr. Gordon G. Esplin

Chief Accounting Officer

Mr. Roger L. Storms

Senior Vice President of Sales

Ms. Pamela Wilson BA

Senior Vice President of Clinical Operations

Mr. Kenneth Wiehe

Senior Vice President of Supply Chain & Manufacturing

Mr. Alan H. Auerbach

Founder, Chairman, President, CEO & Secretary

Mr. Maximo F. Nougues

CFO & Principal Accounting Officer

Mr. Mariann Ohanesian

Senior Director of Investor Relations

Ms. Heather Blaber

Senior Vice President of Marketing

Dr. Petra Rietschel

Senior Vice President of Clinical Development

FAQs

What is Puma Biotechnology share price today?

Puma Biotechnology share price today is $9.60 as on at the close of the market. Puma Biotechnology share today touched a day high of $9.66 and a low of $9.44.

What is the 52 week high and 52 week low for Puma Biotechnology share?

Puma Biotechnology share touched a 52 week high of $9.74 on and a 52 week low of $4.37 on . Puma Biotechnology stock price today i.e. is closed at $9.60,which is 1.39% down from its 52 week high and 119.68% up from its 52 week low.

What is Puma Biotechnology's market capitalisation today?

Puma Biotechnology market capitalisation is $0.00T as on .

How to invest in Puma Biotechnology Stock (PBYI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Puma Biotechnology on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Puma Biotechnology Shares that will get you 0.1563 shares as per Puma Biotechnology share price of $9.60 per share as on September 19, 2026 at 8:45 am IST.

What is the minimum amount required to buy Puma Biotechnology Stock (PBYI) from India?

Indian investors can start investing in Puma Biotechnology (PBYI) shares with as little as ₹95.88 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.80 in Puma Biotechnology stock (as per the Rupee-Dollar exchange rate as on ). Based on Puma Biotechnology share’s latest price of $9.60 as on September 19, 2026 at 8:45 am IST, you will get 1.0417 shares of Puma Biotechnology. Learn more about fractional shares .

What are the returns that Puma Biotechnology has given to Indian investors in the last 5 years?

Puma Biotechnology stock has given 37.97% share price returns and 30.29% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?